ArticleJournal of the anus, rectum and colon2026
Clinicopathological Features and Prognostic Impact of Colorectal Signet-Ring Cell Carcinoma: The Prognostic Impact of Metastatic Lymph Node Histology.
Article in Journal of the anus, rectum and colon, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Colorectal signet-ring cell carcinoma (SRCC) is a rare histological subtype, accounting for only 0.2-0.9% of all colorectal cancers, and is often diagnosed at an advanced stage with a poor prognosis. However, the clinicopathological and prognostic characteristics of colorectal cancers with SRCC components remain poorly defined. Methods: We retrospectively analyzed 35 patients who underwent surgical resection for primary colorectal cancer containing SRCC components between September 2002 and December 2022 at the Shizuoka Cancer Center. The patients were divided into two groups according to the predominant histological subtype: SRCC (n = 7) and adenocarcinoma with a signet-ring cell component (AC with SRC; n = 28). Clinicopathological features and survival outcomes were compared between the groups. Among the patients with lymph node metastasis, survival was compared according to the presence of SRCC in the metastatic lymph nodes (LNM SRCC+, n = 13; LNM SRCC-, n = 13). Results: Of the 35 patients, 7 were classified as having SRCC and 28 as having AC with SRC. Most cases were T3 or deeper tumors (85.7%), with frequent lymphatic invasion (82.9%) and lymph node metastasis (74.3%). The prognosis did not differ between SRCC and AC with SRC, whereas the presence of SRCC in metastatic lymph nodes was associated with significantly poorer overall and relapse-free survival (P = 0.048 and 0.012, respectively). Conclusions: Colorectal cancers with SRCC components are typically advanced and aggressive. The presence of SRCC components confers a poor prognosis, and SRCC in metastatic lymph nodes represents an important adverse prognostic indicator.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.